All (n = 80) | Aβ+1 (n = 38) | Aβ−1 (n = 42) | p-value2 | |
---|---|---|---|---|
Age [years, median ± MAD] | 68 ± 8.9 | 71 ± 7.4 | 65 ± 5.9 | 0.0056 |
Female | 46 (57.5%) | 23 (60.53%) | 23 (54.76%) | |
Male | 34 (42.5%) | 15 (39.47%) | 19 (45.24%) | |
ApoE4 carrier | 37 (46.25%) | 29 (76.3%) | 8 (19.05%) | |
CSF Aβ42/40 [median ± MAD] | 0.062 ± 0.031 | 0.036 ± 0.008 | 0.078 ± 0.010 | < 0.0001 |
CSF Aβ42 [pg/mL, median ± MAD] | 706.5 ± 354.3 | 467.5 ± 161.6 | 893.0 ± 276.5 | < 0.0001 |
CSF Aβ40 [pg/mL, median ± MAD] | 11820.0 ± 3724.3 | 12423.0 ± 4548.6 | 10835.5 ± 3407.8 | 0.0803 |
CSF t-Tau [pg/mL, median ± MAD] | 328.0 ± 197.2 | 476.5 ± 172.7 | 205.0 ± 71.9 | < 0.0001 |
CSF pTau-181 [pg/mL, median ± MAD]3 | 51.7 ± 23.9 | 74.6 ± 23.7 | 36.5 ± 9.9 | < 0.0001 |